The low FODMAP diet: Many question marks for a catchy acronym

Nutrients

Volumn 9, Issue 3, 2017, Pages

  Catassi, Giulia ^a   Lionetti, Elena ^a   Gatti, Simona ^a   Catassi, Carlo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Fermentable sugars; Irritable bowel syndrome; Low FODMAP diet; Non celiac gluten sensitivity; Nutritional risk; Polyols

Indexed keywords

FRUCTOSE; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; ISOMALT; LACTOSE; MALTITOL; MANNITOL; POLYDEXTROSE; POLYOL; SORBITOL; UNCLASSIFIED DRUG; XYLITOL; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYMER; TRACE ELEMENT;

CALCIUM ABSORPTION; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISEASE SEVERITY; DIVERTICULITIS; FECES; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOMODULATION; IRRITABLE COLON; LOW CARBOHYDRATE DIET; MICROBIAL GROWTH; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; REVIEW; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; BLOOD; DEFICIENCY; DIARRHEA; DIET; FERMENTATION; FOOD HANDLING; FOOD PREFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DIARRHEA; DIET; FERMENTATION; FOOD HANDLING; FOOD PREFERENCES; HUMANS; IRRITABLE BOWEL SYNDROME; MICRONUTRIENTS; MONOSACCHARIDES; OLIGOSACCHARIDES; POLYMERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85015874126     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9030292     Document Type: Review

References (41)

1. Gibson, P.; Shepherd, S.J. Personal view: Food for thought—Western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment. Pharmacol. Ther. 2005, 21, 1399–1409. [CrossRef] [PubMed]
2. Gibson, P.R.; Shepherd, S.J. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J. Gastroenterol. Hepatol. 2010, 25, 252–258. [CrossRef] [PubMed]
3. Biesiekierski, J.R.; Peters, S.L.; Newnham, E.D.; Rosella, O.; Muir, J.G.; Gibson, P.R. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013, 145, 320–328. [CrossRef] [PubMed]
4. Shepherd, S.; Gibson, P. The Complete Low FODMAP Diet: A Revolutionary Plan for Managing IBS and Other Digestive Disorders, 1st ed.; The Experiment, LLC: New York, NY, USA, 2013.
5. McKenzie, Y.A.; Bowyer, R.K.; Leach, H.; Gulia, P.; Horobin, J.; O’Sullivan, N.A.; Pettitt, C.; Reeves, L.B.; Seamark, L.; Williams, M.; et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J. Hum. Nutr. Diet. 2016, 29, 549–575. [CrossRef] [PubMed]
6. Marsh, A.; Eslick, E.M.; Eslick, G.D. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur. J. Nutr. 2016, 55, 897–906. [CrossRef] [PubMed]
7. Uno, Y.; van Velkinburgh, J.C. Logical hypothesis: Low FODMAP diet to prevent diverticulitis. World. J. Gastrointest. Pharmacol. Ther. 2016, 7, 503–512. [CrossRef] [PubMed]
8. Lis, D.; Ahuja, K.D.; Stellingwerff, T.; Kitic, C.M.; Fell, J. Case Study: Utilizing a Low FODMAP Diet to Combat Exercise-Induced Gastrointestinal Symptoms. Int. J. Sport. Nutr. Exerc. Metab. 2016, 26, 481–487. [CrossRef] [PubMed]
9. Durchschein, F.; Petritsch, W.; Hammer, H.F. Diet therapy for inflammatory bowel diseases: The established and the new. World. J. Gastroenterol. 2016, 22, 2179–2194. [PubMed]
10. Staudacher, H.M.; Irving, P.M.; Lomer, M.C.; Whelan, K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 256–266. [CrossRef] [PubMed]
11. Sabater-Molina, M.; Larqué, E.; Torrella, F.; Zamora, S. Dietary fructooligosaccharides and potential benefits on health. J. Physiol. Biochem. 2009, 65, 315–328. [CrossRef] [PubMed]
12. Andoh, A.; Tsujikawa, T.; Fujiyama, Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharm. Des. 2003, 9, 347–358. [CrossRef] [PubMed]
13. Blachier, F.; Beaumont, M.; Andriamihaja, M.; Davila, A.M.; Lan, A.; Grauso, M.; Armand, L.; Benamouzig, R.; Tomé, D. Changes in the Luminal Environment of the Colonic Epithelial Cells and Physiopathological Consequences. Am. J. Pathol. 2017, 187, 476–486. [CrossRef] [PubMed]
14. Yao, C.K.; Tan, H.-L.; van Langenberg, D.R.; Barrett, J.S.; Rose, R.; Liels, K.; Gibson, P.-R.; Muir, J.G. Dietary sorbitol and mannitol: Food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2014, 27, S263–S275. [CrossRef] [PubMed]
15. Biesiekierski, J.R.; Rosella, O.; Rose, R.; Liels, K.; Barrett, J.S.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J. Hum. Nutr. Diet. 2011, 24, 154–176. [CrossRef] [PubMed]
16. Muir, J.G.; Rose, R.; Rosella, O.; Liels, K.; Barrett, J.S.; Shepherd, S.J.; Gibson, P.R. Measurement of Short-Chain Carbohydrates in Common Australian Vegetables and Fruits by High-Performance Liquid Chromatography (HPLC). J. Agric. Food Chem. 2009, 57, 554–565. [CrossRef] [PubMed]
17. Liang, Z.; Sang, M.; Fan, P.; Wu, B.; Wang, L.; Duan, W.; Li, S. Changes of polyphenols, sugars, and organic acid in 5 Vitis genotypes during berry ripening. J. Food Sci. 2011, 76, C1231–C1238. [CrossRef] [PubMed]
18. Shepherd, S.J.; Parker, F.C.; Muir, J.G.; Gibson, P.R. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence. Clin. Gastroenterol. Hepatol. 2008, 6, 765–771. [CrossRef] [PubMed]
19. Staudacher, H.M.; Whelan, K.; Irving, P.M.; Lomer, M.C. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2011, 24, 487–495. [CrossRef] [PubMed]
20. Staudacher, H.M.; Lomer, M.C.; Anderson, J.L.; Barrett, J.S.; Muir, J.G.; Irving, P.M.; Whelan, K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J. Nutr. 2012, 142, 1510–1518. [CrossRef] [PubMed]
21. De Roest, R.H.; Dobbs, B.R.; Chapman, B.A.; Batman, B.; O’Brien, L.A.; Leeper, J.A.; Hebblethwaite, C.R.; Gearry, R.B. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int. J. Clin. Pract. 2013, 67, 895–903. [CrossRef] [PubMed]
22. Halmos, E.P.; Christophersen, C.T.; Bird, A.R.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015, 64, 93–100. [CrossRef] [PubMed]
23. Pedersen, N.; Andersen, N.N.; Végh, Z.; Jensen, L.; Ankersen, D.V.; Felding, M.; Simonsen, M.H.; Burisch, J.; Munkholm, P. Ehealth: Low FODMAP diet vs. Lactobacillus rhamnosus GG in irritable bowel syndrome. World. J. Gastroenterol. 2014, 20, 16215–16226. [CrossRef] [PubMed]
24. Chumpitazi, B.P.; Cope, J.L.; Hollister, E.B.; Tsai, C.M.; McMeans, A.R.; Luna, R.A.; Versalovic, J.; Shulman, R.J. Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2015, 42, 418–427. [CrossRef] [PubMed]
25. Böhn, L.; Störsrud, S.; Liljebo, T.; Collin, L.; Lindfors, P.; Törnblom, H.; Simrén, M. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology 2015, 149, 1399–1407. [CrossRef] [PubMed]
26. Whigham, L.; Joyce, T.; Harper, G.; Irving, P.M.; Staudacher, H.M.; Whelan, K.; Lomer, M.C. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J. Hum. Nutr. Diet. 2015, 28, 687–696. [CrossRef] [PubMed]
27. McIntosh, K.; Reed, D.E.; Schneider, T.; Dang, F.; Keshteli, A.H.; de Palma, G.; Madsen, K.; Bercik, P.; Vanner, S. FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut 2016. [CrossRef] [PubMed]
28. Peters, S.L.; Yao, C.K.; Philpott, H.; Yelland, G.W.; Muir, J.G.; Gibson, P.R. Randomised clinical trial: The efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment. Pharmacol. Ther. 2016, 44, 447–459. [CrossRef] [PubMed]
29. Laatikainen, R.; Koskenpato, J.; Hongisto, S.M.; Loponen, J.; Poussa, T.; Hillilä, M.; Korpela, R. Randomised clinical trial: Low FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Aliment. Pharmacol. Ther. 2016, 44, 460–470. [CrossRef] [PubMed]
30. Valeur, J.; Røseth, A.G.; Knudsen, T.; Malmstrøm, G.H.; Fiennes, J.T.; Midtvedt, T.; Berstad, A. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. Digestion 2016, 94, 50–56. [CrossRef] [PubMed]
31. Eswaran, S.L.; Chey, W.D.; Han-Markey, T.; Ball, S.; Jackson, K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am. J. Gastroenterol. 2016, 111, 1824–1832. [CrossRef] [PubMed]
32. Major, G.; Pritchard, S.; Murray, K.; Alappadan, J.P.; Hoad, C.L.; Marciani, L.; Gowland, P.; Spiller, R. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology 2017, 152, 124–133. [CrossRef] [PubMed]
33. Hustoft, T.N.; Hausken, T.; Ystad, S.O.; Valeur, J.; Brokstad, K.; Hatlebakk, J.G.; Lied, G.A. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol. Motil. 2016. [CrossRef] [PubMed]
34. The National Institute for Health and Care Excellence. NICE Clinical Guidelines, No 61. Irritable Bowel Syndrome in Adults: Diagnosis and Management of Irritable Bowel Syndrome in Primary Care; Last Updated: February 2015; National Collaborating Centre for Nursing and Supportive Care: London, UK; Royal College of Nursing: London, UK, February 2008.
35. Maagaard, L.; Ankersen, D.V.; Végh, Z.; Burisch, J.; Jensen, L.; Pedersen, N.; Munkholm, P. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J. Gastroenterol. 2016, 22, 4009–4019. [CrossRef] [PubMed]
36. Rajilić-Stojanović, M.; Jonkers, D.M.; Salonen, A.; Hanevik, K.; Raes, J.; Jalanka, J.; de Vos, W.M.; Manichanh, C.; Golic, N.; Enck, P.; et al. Intestinal microbiota and diet in IBS: Causes, consequences, or epiphenomena? Am. J. Gastroenterol. 2015, 110, 278–287. [CrossRef] [PubMed]
37. Vici, G.; Belli, L.; Biondi, M.; Polzonetti, V. Gluten free diet and nutrient deficiencies: A review. Clin. Nutr. 2016, 35, 1236–1241. [CrossRef] [PubMed]
38. Infante, D.; Tormo, R. Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J. Pediatr. Gastroenterol. Nutr. 2000, 30, 310–313. [CrossRef] [PubMed]
39. Abrams, S.A.; Griffin, I.J.; Davila, P.M. Calcium and zinc absorption from lactose-containing and lactose-free infant formulas. Am. J. Clin. Nutr. 2002, 76, 442–446. [PubMed]
40. Brewer, M.S. Natural antioxidants: Sources, compounds, mechanisms of action, and potential applications. Compr. Rev. Food Sci. Food Saf. 2011, 10, 221–247. [CrossRef]
41. Gröber, U.; Reichrath, J.; Holick, M.F. Live Longer with Vitamin D? Nutrients 2015, 7, 1871–1880. [CrossRef] [PubMed]